Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Herold, Susanne
GI-HOPE, NCT02595060 / 2014-002479-28: Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Inhalation to Improve Host Defense and Pulmonary Barrier Restoration	Completed	2	45	Europe	inhaled molgramostim (rhGM-CSF), inhaled placebo	University of Giessen	ARDS	09/21	07/22
GI-COVID, NCT04569877: GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia	Completed	2	63	Europe	Molgramostim nebuliser solution, Placebo nebuliser solution	University of Giessen	Severe Acute Respiratory Syndrome (SARS) Pneumonia, COVID-19 Pneumonia	06/22	09/22